Trial Profile
A phase 1, randomized, multiple dose, double blind, 5-way crossover study of the electrocardiographic effects of bilastine in healthy adult subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Apr 2012
Price :
$35
*
At a glance
- Drugs Bilastine (Primary) ; Ketoconazole; Moxifloxacin
- Indications Allergic rhinitis; Allergic rhinoconjunctivitis
- Focus Adverse reactions
- Sponsors FAES Farma
- 14 Dec 2007 Status change from inprogress to completed.
- 07 Feb 2007 New trial record.